Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
Hemabate Sterile Solution.
| Pharmaceutical Form |
|---|
|
Solution for injection. Colourless, sterile, aqueous solution for intramuscular injection. |
Each 1 ml contains carboprost tromethamine equivalent to carboprost 250 micrograms.
Excipient(s) with known effect:
This medicine contains 9.45 mg benzyl alcohol in each ampoule which is equivalent to 9.45 mg/ml.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carboprost |
Carboprost is a synthetic 15-methyl analogue of dinoprost (prostaglandin F2 alpha). Administered intramuscularly carboprost stimulates in the gravid uterus myometrial contractions similar to labor contractions at the end of a full term pregnancy. It is indicated for aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and for the treatment of postpartum hemorrhage due to uterine atony, which has not responded to conventional methods of management. The most frequent adverse reactions observed are related to its contractile effect on smooth muscle: vomiting, diarrhea, nausea, fever and flushing. Carboprost may augment the activity of other oxytocic agents. Concomitant use with other oxytocic agents is not recommended. |
| List of Excipients |
|---|
|
Benzyl alcohol |
Ampoule: Type 1 glass ampoule containing 1 ml solution, packed in cartons of two or ten ampoules.
Vial: Type 1 glass with butyl rubber closure, containing 10 ml solution, packed individually in a carton.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
PL 00057/1000
Date of first authorisation: 16 August 1990
Date of latest renewal: 23 February 1996
| Drug | Countries | |
|---|---|---|
| HEMABATE | Canada, Hong Kong, Singapore, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
